April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Emily E. Bosco: AstraZeneca will be presenting 14 abstracts in cancer immunotherapy at SITC 2024
Nov 7, 2024, 12:38

Emily E. Bosco: AstraZeneca will be presenting 14 abstracts in cancer immunotherapy at SITC 2024

Emily E. Bosco, Senior Director in Cell Therapy, Early oncology at AstraZeneca, shared on LinkedIn:

“At SITC 2024, AstraZeneca will be presenting 14 abstracts that demonstrate our progress in cancer immunotherapy.

A highlight will be the sharing of preclinical data from our novel Target Induced T cell Activating Nanobody (TITAN) platform, including the first disclosure of a TITAN T-cell engager intended for use in solid tumours.

Recent advances in our understanding of the immune system are driving the development of the next generation of immunotherapies, and we’re pushing the boundaries of science to reimagine cancer care and help transform outcomes for patients.

Find out more our focus areas in immunotherapy here.”

AstraZeneca

More posts featuring AstraZeneca on oncodaily.com